Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients.
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2015
At a glance
- Drugs Interferon beta (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms SEPTIME
- Sponsors Merck KGaA
- 06 Feb 2012 Merck Serono as company and lead trial centre identified as reported by ClinicalTrials.gov.
- 20 Sep 2010 New trial record